Phototherapy is commonly used for neonatal jaundice but greater control is needed to avoid toxicity in the most vulnerable infants
| Autor: | Hans Jørgen Stensvold, Jūratė Šaltytė Benth, Thor Willy Ruud Hansen, Britt Nakstad, Khalaf Mreihil |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Neonatal intensive care unit Gestational Age Norwegian 03 medical and health sciences 0302 clinical medicine Intensive Care Units Neonatal 030225 pediatrics Intensive care medicine Birth Weight Humans 030212 general & internal medicine Intensive care medicine Norway business.industry Patient Selection Infant Newborn Gestational age General Medicine Phototherapy Jaundice language.human_language Jaundice Neonatal Discontinuation Pediatrics Perinatology and Child Health Toxicity language Population study Female medicine.symptom business |
| Zdroj: | Acta Paediatrica. 107:611-619 |
| ISSN: | 0803-5253 |
| Popis: | AIM: Limited information is available about how guidelines on phototherapy for neonatal jaundice are applied in practice and toxicity is a concern. We studied the use of phototherapy in relation to birthweight and gestational age (GA) in Norwegian neonatal intensive care units (NICUs). METHODS: The study population was all 5382 infants admitted to the 21 NICUs in Norway between September 1, 2013 and August 31, 2014. Data were recorded daily in the Norwegian Neonatal Network database and anonymised data on patient characteristics, diagnoses, duration, the ages at the start and discontinuation of phototherapy were analysed. RESULTS: More than a quarter (26.6%) of all infants admitted to Norwegian NICUs during the study period received phototherapy. The use of phototherapy was inversely related to GA and birthweight. More than 80% of the preterm infants under 28 weeks of GA received phototherapy. The duration was significantly longer in the lowest birthweight and GA groups and decreased with increasing birthweight and GA. CONCLUSION: Phototherapy is proved to be a strong candidate for the most common therapeutic modality in NICU infants. However, in the light of reported toxicity in the smallest, most vulnerable infants, we recommend increased emphasis on quality control. The final version of this research has been published in Acta Paediatrica. © 2017 Wiley |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text